Research
Research grants
Chemical stress.
WELLCOME TRUST (UK)
August 2004 - September 2004
Development of an in vitro microsomal assay that can determine the rate of consumption of reduced glutathione
WELLCOME TRUST (UK)
July 2011 - August 2011
Mechanistic investigation into novel rodenticides
BASF PLC (UK)
February 2010 - January 2013
University of Liverpool Institutional Discipline Bridging.
MEDICAL RESEARCH COUNCIL
October 2003 - October 2006
Role of inflammation in organ-selective off target adverse drug reactions
MINISTRY OF HIGHER EDUCATION (MALAYSIA)
July 2012 - June 2015
Towards NanoMedicine Interventions for HIV/AIDS
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
May 2012 - November 2016
In vivo physiological mechanisms underlying a1-adrenoceptor mediated protection during drug-induced hepatotoxicity in the mouse
BIOTECHNOLOGY & BIOLOGICAL SCIENCE RESEARCH COUNCIL
October 2007 - September 2008
Investigation of Inflammatory Signalling during Drug-induced Hepatotoxicity Background
BRITISH TOXICOLOGY SOCIETY (UK)
October 2007 - September 2010
The chemical and molecular basis of the prevention of drug-induced liver injury by Nrf2.
WELLCOME TRUST (UK)
January 2007 - December 2009
Investigation into drug toxicity using high density array analysis corroborated with Northern Blot, real time PCR and RT-PCR.
WELLCOME TRUST (UK)
July 2001 - September 2001
Hepatocyte protein adduct formation with paracetamol and furosemide.
WELLCOME TRUST (UK)
June 2005 - August 2005
Paracetamol and PARP inhibitors
ASTRAZENECA LIMITED (UK)
November 2010 - February 2012
Research collaborations
Gallagher / Jarvis
Alkaptonuria research
Prof ANja Kipar
CDSS Pathology collaboration
Integrative Toxicology Training Programme
Medical Research Council
Research & Development
Sorex, BASF
New Opportunities Group
AstraZeneca Pharmceuticals
Group
AstraZeneca Pharmceuticals
Drug-induced hepatic toxicity
Group
Pfizer Ltd
Investigation of reactive and potentially toxic intermediates
Transmitter Group
The University of Nottingham
Measurement of serum catecholamines
Group
AstraZeneca Pharmceuticals
Bioactivation of drugs
Group
Pfizer Ltd
Transcription factor activation as safety assessment